Rotational Rheometer System

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

75F40126Q133238

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6640

Additional Details
Set Aside

None

Place of Performance

Silver Spring, Maryland, UNITED STATES

SourceSAM
Documents2
The Food and Drug Administration (FDA), operating under the Department of Health and Human Services, has issued a Combined Synopsis/Solicitation for the procurement of a Rotational Rheometer System. This opportunity, identified by procurement number 75F40126Q133238, is intended to support the FDA’s analytical laboratory capabilities at its facility in Silver Spring, Maryland. The primary purpose of this procurement is to acquire a state-of-the-art rotational rheometer system, which is essential for advanced material characterization and analysis within FDA laboratories. The scope of the acquisition encompasses the delivery of a complete analytical instrument, manufactured in accordance with the standards outlined under NAICS Code 334516 (Analytical Laboratory Instrument Manufacturing). The expected outcome is to enhance the FDA’s capacity for precise measurement and evaluation of material properties, thereby supporting regulatory science and research initiatives. Key requirements for this solicitation include the provision of a rotational rheometer system that meets the technical specifications detailed in the attached Combined Synopsis/Solicitation document. Contractors are expected to deliver a fully functional system, suitable for installation and operation at the FDA’s Silver Spring location. The deliverables will likely include the instrument itself, any necessary accessories, and documentation to support installation, calibration, and ongoing use. While the full technical requirements are contained in the solicitation attachment, the procurement is classified under Product Service Code 6640, which pertains to laboratory equipment and supplies. The contracting entity for this opportunity is the FDA Office of Acquisition and Grant Services, a federal office responsible for managing procurement activities for the agency. The primary point of contact for this solicitation is Howard Nesmith, who can be reached via email at [email protected] or by phone at 301-796-2138. Interested contractors should direct all inquiries and responses to Mr. Nesmith. This procurement is being conducted as a Combined Synopsis/Solicitation, streamlining the process for both announcement and receipt of offers. The notice is currently active, with a posting date of April 6, 2026, and a response deadline of December 6, 2026, at 18:06. Contractors are encouraged to review the solicitation documents available through the provided SAM.gov link for complete details and submission instructions. There is no information provided regarding set-aside requirements or special considerations, so contractors should consult the attached documents for any such provisions. In summary, this opportunity represents a significant investment in laboratory instrumentation for the FDA, with the goal of advancing analytical capabilities in support of public health and regulatory missions. Contractors with expertise in analytical laboratory instrument manufacturing and the ability to supply high-quality rotational rheometer systems are encouraged to evaluate the solicitation and consider submitting a proposal.